Type 1 phosphatase, a negative regulator of cardiac function

Andrew N. Carr, Albrecht G. Schmidt, Yoichi Suzuki, Federica Del Monte, Yoji Sato, Carita Lanner, Kristine Breeden, Shao Ling Jing, Patrick B. Allen, Paul Greengard, Atsuko Yatani, Brian D. Hoit, Ingrid L. Grupp, Roger J. Hajjar, Anna A. DePaoli-Roach, Evangelia G. Kranias

研究成果: Article査読

217 被引用数 (Scopus)

抄録

Increases in type 1 phosphatase (PP1) activity have been observed in end stage human heart failure, but the role of this enzyme in cardiac function is unknown. To elucidate the functional significance of increased PP1 activity, we generated models with (i) overexpression of the catalytic subunit of PP1 in murine hearts and (ii) ablation of the PP1-specific inhibitor. Overexpression of PP1 (threefold) was associated with depressed cardiac function, dilated cardiomyopathy, and premature mortality, consistent with heart failure. Ablation of the inhibitor was associated with moderate increases in PP1 activity (23%) and impaired β-adrenergic contractile responses. Extension of these findings to human heart failure indicated that the increased PP1 activity may be partially due to dephosphorylation or inactivation of its inhibitor. Indeed, expression of a constitutively active inhibitor was associated with rescue of β-adrenergic responsiveness in failing human myocytes. Thus, PP1 is an important regulator of cardiac function, and inhibition of its activity may represent a novel therapeutic target in heart failure.

本文言語English
ページ(範囲)4124-4135
ページ数12
ジャーナルMolecular and cellular biology
22
12
DOI
出版ステータスPublished - 2002
外部発表はい

ASJC Scopus subject areas

  • 分子生物学
  • 細胞生物学

フィンガープリント

「Type 1 phosphatase, a negative regulator of cardiac function」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル